One-year outcomes following intravitreal aflibercept for polypoidal choroidal vasculopathy in Japanese patients: The APOLLO Study
Ophthalmologica Aug 17, 2017
Oshima Y, et al. – This article strived to assess the 1–year outcomes of intravitreal injections of aflibercept (IVA) in Japanese polypoidal choroidal vasculopathy (PCV) patients. It was inferred that 1 year of IVA led to a stabilization of best–corrected visual acuity (BCVA) and anatomical improvement in Japanese PCV patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
